News for MediWound Ltd. (MDWD)

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (VCEL), a leader in advanced therapies for the sports medicine and severe burn care m

Conference call and webcast scheduled for Wednesday, March 19th at 8:30 a.m. Eastern Time YAVNE, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Full-Year Total Revenue Growth of 20% to $237.2 Million, with MACI Revenue Growth of 20% and Burn Care Revenue Growth of 22% Full-Year Adjusted EBITDA Growth o

Findings in Burns Journal confirm NexoBrid's superiority over standard of care in pediatric patients with deep thermal burnsNexoBrid is approved for pediatric u

YAVNE, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. ( MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today an

Transaction Overview On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring an additional 9,536,647 shares in Biof

**media[538614]**

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a significant move by adding 412,087 shares of OptiNose Inc. (NASDAQ: OPTN) to its portfo

Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Reven

**media[515144]**

**media[509425]**

On November 12, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring 2,100,840 shares of Neuraxis Inc (NRXS). This transaction,

Revenue (Q3 2024): $4.4 million, down from $4.8 million in Q3 2023.Gross Profit (Q3 2024): $0.7 million, representing 16% of total revenue, compared to $0.9 mi

Nov 26, 2024 / 01:30PM GMTOperator Good day, and welcome to the MediWound third-quarter 2024 earnings call. (Operator instructions) Please note this event is be

MediWound Ltd. (NASDAQ:MDWD) Q3 2024 Earnings Conference Call November 26, 2024 8:30 AM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsOfer Gonen -...

**media[476518]**

MediWound Ltd (MDWD) is set to release its Q3 2024 earnings on Nov 26, 2024. The consensus estimate for Q3 2024 revenue is $6.01 million, and the earnings are e